Rock Creek Pharmaceuticals Inc. (fka RCPIQ)

[Buddhahead]

Rock Creek Pharmaceuticals $232770 Financing. Benjamin M Dent Filled May 18 form at OCTA Finance

Article:
"Rock Creek Pharmaceuticals Financing

Rock Creek Pharmaceuticals, Inc., Corporation just submitted form D for $232,770 equity financing. This is a new filing. Rock Creek Pharmaceuticals was able to finance itself with $232,770. That is 100.00% of the financing offer. The total offering amount was $232,770. The form was filled on 2015-05-18. The reason for the financing was: unspecified.
Rock Creek Pharmaceuticals is based in Florida. The firm’s business is not disclosed. The D form was submitted by Benjamin M Dent Chief Financial Officer. The company was incorporated more than five years ago. The filler’s address is: 2040 Whitfield Avenue, Suite 300, Sarasota, Fl, Florida, 34243. Michael J. Mullan is the related person in the form and it has address: 2040 Whitfield Avenue, Suite 300, Sarasota, Fl, Florida, 34243. Link to Rock Creek Pharmaceuticals Filing: 000114036115020808.
Analysis of Rock Creek Pharmaceuticals Offering

On average, firms in the not disclosed sector, sell 67.77% of the total offering amount. Rock Creek Pharmaceuticals sold 100.00% of the offering. Could this mean that the trust in Rock Creek Pharmaceuticals is high? The average fundraising amount for companies in all industries in our database is $3.05 million. The offering was 92.37% smaller than the average of $3.05 million. Of course this should not be interpreted as negative. Startups get financed for different needs and reasons. The minimum investment for this financing is set at $0. If you know more about the reasons for the financing, please comment below.
What is Form D? What It Is Used For

Form D disclosures could be used to track and understand better your competitors. The information in Form D is usually highly confidential for ventures and startups and they don’t like revealing it. This is because it reveals amount raised or planned to be raised as well as reasons for the financing. This could help competitors. Entrepreneurs usually want to keep their financing a ‘secret’ so they can stay in stealth mode for longer.
Why Fundraising Reporting Is Good For Rock Creek Pharmaceuticals Also

The Form D signed by Benjamin M Dent might help Rock Creek Pharmaceuticals, Inc.’s business. First, it helps potential customers feel more safe to deal with a firm that is well financed. The odds are higher that it will stay in the business. Second, this could attract other investors such as venture-capital firms, funds and angels. Third, positive PR effects could even bring leasing firms and venture lenders."

Article at:
http://www.octafinance.com/rock-creek-pharmaceuticals-232770-financing-benjamin-m-dent-filled-may-18-form/